Icon
+91 94997 68112
Login Register

Odefsey - (200 mg; Eq 25 mg; Eq 25 mg , Tablet, Oral)

Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate Gilead
200 mg; Eq 25 mg; Eq 25 mg , Tablet, Oral
More Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg: as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL
Yes
******, ***** *** ***** *** ****. ****** ***** * **** ** ** ****** '*** *** '***. ***** *** ***** ***** * **** ** ** ******* '***, '***, '***, '***. ** ****** **** **** **** ****** ** *** ****. ********* ** *** ****** ** ******, ******** ****** ****** ** ****.
Odefsey Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
****** *** ********* *** ********* *** ********* *** ********* *** ********* ******* *** ********* *** ********* ******* *******
***** *** ********* *** ********* *** ********* *** ********* ******* ******* *** ********* *** ********* ******* *******
***** *** ********* *** ********* *** ********* *** ********* ******* ******* *** ********* *** ********* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* *** *, **** ******* **** ** *** **, ****
***** *** \ ********* *** *, **** ******* ********* ******** ** *** **, ****
***** *** \ ********* *** *, **** ******* **** ** *** **, ****
  1. *** **, **** : ****** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  2. *** *, **** : ***** ******** ****** ***** **'* **** ** ****** ** ******* '***, '***, '*** *** '***.
  3. *** **, **** : ***** ******** ****** ***** **'* **** ** ****** ** ******* '***, '***, '*** *** '***.
  4. *** *, **** : ****** ***** * **** ******* ****** ** ******* '*** *** '***.
  5. *** *, **** : ****** ***** * **** ******* ***** *** ***** ** ******* '***, '***, '*** *** '***.
  6. *** **, **** : ***** ****** ** ****** *** **** ** ************* ** ******* '*** *** '***
  7. *** **, **** : ****** ***** * **** ******* ******, ***** *** ***** ** ****** '*** '*** '*** *** '***
  8. *** *, **** : ****** ******* ********** **** ****** *** *****.
  9. *** **, **** : ****** ******* ********** **** *****.
  10. *** **, **** : ********* ** ********** ********* ***** ** ******'* *** ******, *** ******** *** ****** ** *** **, ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.